Sanofi Menactra Adverse Event Reports Prompt Letter To Providers
At FDA's request, Sanofi Pasteur is informing customers of five reported cases of Guillain Barre syndrome that occurred after administration of the mengingococcal vaccine.
At FDA's request, Sanofi Pasteur is informing customers of five reported cases of Guillain Barre syndrome that occurred after administration of the mengingococcal vaccine.